• 1
    Consensus statement EASL. J Hepatol 1999; 30:956961.
  • 2
    Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98:706714.
  • 3
    Diepolder HM, Zachoval R, Hoffman RM, Wierenga E, Santantonio T, Jung MC, Elchenlaub D, et al. Possible mechanisms involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346:10061007.
  • 4
    Diepolder HM, Gerlach JY, Zachoval R, Hoffman RM, Jung MC, Wierenga E, Scholz S, et al. Immunodominant CD4+ T-cell epitope within non-structural protein 3 in acute hepatitis C virus infection. J Virol 1997; 71:60116019.
  • 5
    Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type-2 like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25:449458.
  • 6
    Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, Sette A, et al. Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: implications for vaccine development. Hepatology 1999; 30:10881098.
  • 7
    Lechner F, Wong DKH, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191:14991512.
  • 8
    Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:13951406.
  • 9
    Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001; 75:55505558.
  • 10
    Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10:439449.
  • 11
    Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, Sidney J, McKinney D, et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001; 15:883895.
  • 12
    Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000; 6:578582.
  • 13
    Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, et al. T-cell response to structural and non-structural hepatitis C virus antigens is persistent and self-limited in hepatitis C virus infection. Hepatology 1994; 19:286295.
  • 14
    Hoffman RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H, et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21:632638.
  • 15
    Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178:1725.
  • 16
    Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104:580587.
  • 17
    Koziel MJ, Dudley D, Wong J, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149:33393344.
  • 18
    Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995; 69:24622470.
  • 19
    Cerny A, McHutchinson J, Pasquinelli C, Brown M, Brothers M, Grabschied B, Fowler P, et al. CTL response to HCV-derived peptides containing the HLA-A2.1 binding motif. J Clin Invest 1995; 95:521530.
  • 20
    Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, Houghton M, et al. HLA class I restricted cytotoxic T lymphocytes specific for hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995; 96:23112321.
  • 21
    Rehermann B, Chang KM, McHutchinson M, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70:70927102.
  • 22
    Rehermann B, Chang KM, McHutchinson M, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood CTL response in patients with chronic HCV infection. J Clin Invest 1996; 98:14321440.
  • 23
    Nelson DR, Marousis CG, Davis GL, Rice MR, Wong J, Houghton M, Lau JYN. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158:14731481.
  • 24
    Wong DKH, Dudley D, Afdhal NH, Dienstag J, Rice CM, Wang L, Houghton M, et al. Liver derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998; 160:14791488.
  • 25
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A. Identification of HLA-A3 and B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol 1999; 162:11561164.
  • 26
    Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HGA, et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 2002; 35:190198.
  • 27
    Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JYN. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology 1998; 28:225230.
  • 28
    Lasarte JJ, Garcia-Granero M, Lopez A, Casares N, Garcia N, Civeira MP, Borras-Cuesta F, et al. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology 1998; 28:815822.
  • 29
    Vertuani S, Bazzaro M, Gualandi G, Micheletti F, Marastoni M, Fortini C, Canella A, et al. Effect of interferon-α therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals. Eur J Immunol 2002; 32:144154.
  • 30
    Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 4:759765.
  • 31
    Lohr HF, Schlaak JF, Kollmannsperger S, Dienes HP, Meyer Zum Buschenfelde KH, Gerken G. Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA restriction and functional significance. Liver 1996; 16:174182.
  • 32
    Schirren CA, Jung MC, Gerlach JT, Worzfeld T, Baretton G, Mamin M, Gruener NU, et al. Liver-derived hepatitis C virus (HCV)-specific CD4+ T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000; 32:597603.
  • 33
    Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search program. Nucleic Acid Res 1997; 25:33893402.
  • 34
    Penna A, DelPrete G, Cavalli A, Bertoletti A, D'Elios M, Sorrentino R, D'Amato M, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25:10221027.
  • 35
    Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197207.
  • 36
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:15131520.
  • 37
    Brunt ME. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000; 31:241246.
  • 38
    Surcel HM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G, Ivanyi J. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994; 81:171176.
  • 39
    Osterborg A, Yi Q, Bergenbrant S, Holm G, Lefvert AK, Mellstedt H. Idiotype-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests. Br J Haematol 1995; 89:110116.
  • 40
    Wang H, Eckels DD. Mutations in imunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol 1999; 162:41774183.
  • 41
    Ciurea A, Hunziker L, Martinic MAM, Oxenius A, Hengartner H, Zinkernagel RM. CD4+ T-cell-epitope escape mutant virus selected in vivo. Nat Med 2001; 7:795800.
  • 42
    Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112:193199.